rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Herceptin

Rediff.com  »  News  »   Herceptin

  News for Herceptin

  • News
  • Business

Olive oil fights breast cancer

Olive oil might be the reason for the low breast cancer rate in Mediterranean nations. Olive oil is high in oleic acid. 'In laboratory experiments using breast-cancer cells, a US team has shown......

India partly revokes Roche cancer drug patent

India has partly revoked patents granted to Roche Holding AG for its breast cancer drug Herceptin, a spokesman for the drugmaker confirmed on Sunday.Swiss newspaper Schweiz am Sonntag reported that......

Biocon contests Roche claims on cancer drug

Biocon has lashed out at Roche a day after the Swiss company secured an order from the Delhi High Court barring the Indian company from marketing its new drug, co-developed with Mylan, as a......

Roche's patent pain to be Biocon's gain

Indian firm to soon launch copycat of anti-breast-cancer drug For Swiss pharma major Roche, not pursuing an Indian patent for its anti-breast-cancer drug, Herceptin, might mean a loss of millions......

'Judgment will ensure no ever-greening of patents'

Though the legal battle over Glivec’s patentability may be over for now, Y K Sapru, the man spearheading the fight against Swiss multinational Novartis, isn’t resting. Sapru, founder......

BDR wrestles Big Pharma in patents match

A month ago, Dharmesh Shah had enough time to spare for day-to-day activities of a lesser-known company -- BDR Pharma -- where he serves as chairman & managing director.However, in the last one......
  Web results for Herceptin
Companion Diagnostics Market (2nd Edition), 2014-2024

From the Wires Nov. 27, 2014 05:29 PM LONDON , Nov. 27, 2014 /PRNewswire/ -- INTRODUCTION With an influx of new technologies and... ...

http://in.sys-con.com/node/3243987
Roche's Genentech defends supply shift for top cancer drugs

By By | Reuters 8 minutes ago (Reuters) - Genentech, U.S. biotech unit of Roche Holding, faces growing pressure over a decision to allow only a... ...

https://in.news.yahoo.com/roches-genentech-defends-supply-shift-top-cancer-drugs-234124744--finance.html
Pooled Analysis Results of Two Phase III HalavenĀ® (eribulin) Trials Published in Breast Cancer Research and Treatment

From the Wires Nov. 12, 2014 07:01 PM HATFIELD, England , November 13, 2014 /PRNewswire/ -- Significant survival benefit observed in... ...

http://in.sys-con.com/node/3225825
Halozyme Therapeutics third-quarter loss widens

me Therapeutics (HALO) saw its loss widen to $20.28 million, or $0.16 a share for the quarter ended Sep. 30, 2014. In the previous year period, the... ...

http://www.myiris.com/newsCentre/storyShow.php?fileR=20141112132409760&dir=2014/11/12&secID=livenews&code1=&code=
Galena Biopharma Doses First Patient in Phase 2 Clinical Trial With NeuVax(TM) (nelipepimut-S) in Combination With Herceptin(R) (trastuzumab) to Treat High-Risk HER2 3+ or HER2 Gene-Amplified Breas

-- Trial expands the eligible patient population and overall NeuVax clinical trial portfolio -- Recent patent allowance provides intellectual... ...

http://www.bizwireexpress.com/showstoryGNW.php?storyid=50042

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z